pd 117302 has been researched along with flurothyl in 1 studies
Studies (pd 117302) | Trials (pd 117302) | Recent Studies (post-2010) (pd 117302) | Studies (flurothyl) | Trials (flurothyl) | Recent Studies (post-2010) (flurothyl) |
---|---|---|---|---|---|
48 | 0 | 2 | 318 | 1 | 56 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Echevarria, E; Hughes, J; Hunter, JC; Robles, L; Tortella, FC | 1 |
1 other study(ies) available for pd 117302 and flurothyl
Article | Year |
---|---|
PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats.
Topics: Animals; Anticonvulsants; Aspartic Acid; Dose-Response Relationship, Drug; Electroshock; Flurothyl; Male; N-Methylaspartate; Pyrroles; Random Allocation; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Thiophenes; Time Factors | 1990 |